https://www.selleckchem.com/products/jq1.html
Cancer treatment is often aimed at achieving rapid, large, and sustained reductions in tumor burden. Even when these strong responses are achieved, treatment frequently fails due to the emergence of drug-resistant cell lineages. Over the last decade, a variety of authors have suggested that treatment should instead be aimed at containing resistance rather than curing the patient. That new philosophy poses a dilemma how to choose between treatment regimens that can sometimes cure the patient and regimens that can delay progression but not cu
Like
Comment
Share
